|Videos|June 16, 2022
Second Opinion: Presbyopia Treatments at Arm’s Length
On this segment of Second Opinion, ophthalmologists Ehsan Sadri, MD, and William Trattler, MD, weigh the advent of various lifestyle eye drops and other advances for presbyopia, an age-related eye condition affects more than 130 million Americans over 40. These innovations are capturing the attention of not only ophthalmologists and optometrists but also primary care physicians and other medical specialists. Drs. Sadri and Trattler dissect the market impact on today’s mainstream consumers.
Related Articles
- Deep Dive: Into Improving Patient Outcomes Through AI
August 16th 2023
- Behind the Science: Behind Chemotherapy Shortages
August 15th 2023
- Deep Dive: Into Types of Chromatography
August 15th 2023
- Deep Dive: Into Clinical Trials & Reproductive Health
August 4th 2023
- Deep Dive: Into Diabetic Retinopathy
August 3rd 2023
- Deep Dive: Into AHN’s Fertility Clinic
August 2nd 2023